TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT04170556 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT04170556 — Predictive Biomarker (PRD): FLT4 mRNA
Genes: FLT4; VEGFR3
Study NCT04170556 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT04170556 — Predictive Biomarker (PRD): CSF1R mRNA
Genes: CSF1R; FMS
Study NCT04170556 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04170556 — Safety Biomarker (SAF): IL-6 and IL-10
Study NCT03161977 — Surrogate Endpoint (SUR): Serum potassium
Study NCT04116242 — Predictive Biomarker (PRD): MERTK mRNA
Genes: MERTK; MER
Study NCT00000521 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01585805 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study NCT03905694 — Predictive Biomarker (PRD): PHC1 mRNA
Genes: PHC1; EDR1; PH1
Study NCT03905694 — Surrogate Endpoint (SUR): Urinary oxalate
Study NCT01191034 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01191034 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05161910 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT03974555 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT04365803 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00051935 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study NCT01783795 — Predictive Biomarker (PRD): CLCN5 mRNA
Genes: CLCN5; CLCK2
Study NCT04109092 — Predictive Biomarker (PRD): STING1 mRNA
Genes: STING1; ERIS; MITA; STING; TMEM173
Study NCT02865135 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT03646994 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT03888066 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT02567279 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01592383 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00082277 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00082277 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01027598 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03180281 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT03142191 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01982955 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT01982955 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01982955 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01456806 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00673816 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00673816 — Predictive Biomarker (PRD): VHL mRNA
Genes: VHL
Study NCT00673816 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03727776 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT03727776 — Safety Biomarker (SAF): Interleukin 1
Study NCT02591914 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01319864 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT00003274 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02759887 — Predictive Biomarker (PRD): DHPS mRNA
Genes: DHPS; DS
Study NCT02759887 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT01114269 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT01114269 — Predictive Biomarker (PRD): CALD1 mRNA
Genes: CALD1; CAD; CDM
Study NCT02295852 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03705429 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03778138 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03778138 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03778138 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT03635476 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00770328 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02881697 — Predictive Biomarker (PRD): RICTOR mRNA
Genes: RICTOR; KIAA1999
Study NCT01998763 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT02759276 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00317694 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT03293472 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00425321 — Pharmacodynamic Biomarker (PDY): Cathepsin S
Genes: CTSS
Study NCT00000543 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02026934 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00550771 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02921152 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02921152 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02178397 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04262921 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05094232 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study NCT02671578 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04573868 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02156388 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT00216086 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT00216086 — Safety Biomarker (SAF): Dihydrothymine dehydrogenase
Genes: DPYD
Study NCT03065192 — Predictive Biomarker (PRD): DDC mRNA
Genes: DDC; AADC
Study NCT02499835 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT02872428 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT00708110 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00625820 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT03317899 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03187210 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT04318587 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT03907254 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study NCT02122991 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04718831 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02956031 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT03618719 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT03400592 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01595685 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00246324 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study NCT06263192 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT02509169 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT02191293 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04640870 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04640870 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02864992 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT03209895 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00005629 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT01627678 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT01627678 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00251290 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00764322 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT04834609 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04433754 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01370018 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01875328 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00570921 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00570921 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02914717 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04379427 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02657928 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03126435 — Predictive Biomarker (PRD): GEM mRNA
Genes: GEM; KIR
Study NCT01371747 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01371747 — Surrogate Endpoint (SUR): Serum potassium
Study NCT03927456 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03927456 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04251247 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT02875990 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03763006 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02153983 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01596790 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02905188 — Predictive Biomarker (PRD): GPC3 mRNA
Genes: GPC3; OCI5
Study NCT03068377 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT01016327 — Predictive Biomarker (PRD): CDC7 mRNA
Genes: CDC7; CDC7L1
Study NCT00490841 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01289483 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02717455 — Predictive Biomarker (PRD): H3-3A mRNA
Genes: H3-3A; H3.3A; H3F3; H3F3A; PP781;; H3-3B; H3.3B; H3F3B
Study NCT04142086 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03971786 — Surrogate Endpoint (SUR): Sperm parameters
Study NCT00445029 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02756611 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT01656057 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT00695474 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00003126 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03282955 — Predictive Biomarker (PRD): LCT mRNA
Genes: LCT; LPH
Study NCT00006464 — Predictive Biomarker (PRD): UCN mRNA
Genes: UCN
Study NCT04412031 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03277066 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT02850692 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT02561325 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04114045 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02762123 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT02762123 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT02762123 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT02023931 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Nqo1 mRNA
Genes: NQO1; DIA4; NMOR1
Study NCT02965417 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02965417 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04077554 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04077554 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03196336 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01838850 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00550459 — Surrogate Endpoint (SUR): Serum sodium
Study NCT00297076 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT03222856 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03222856 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03222856 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03222856 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT02282930 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT05596656 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT00387907 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00404508 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT05565430 — Predictive Biomarker (PRD): AHR mRNA
Genes: AHR; BHLHE76
Study NCT02585778 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT02585778 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02585778 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT03833687 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03106935 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT02498002 — Predictive Biomarker (PRD): CIDEC mRNA
Genes: CIDEC; FSP27
Study NCT00185588 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02605915 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02605915 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04319354 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT04319354 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT04319354 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04319354 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04319354 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT04505566 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04505566 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT00257621 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04313790 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04310176 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT01027702 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT03280264 — Surrogate Endpoint (SUR): Serum intact parathyroid hormone
Study NCT03280264 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT03859544 — Predictive Biomarker (PRD): MYD88 mRNA
Genes: MYD88
Study NCT03859544 — Predictive Biomarker (PRD): TBL1XR1 mRNA
Genes: TBL1XR1; IRA1; TBLR1
Study NCT04456088 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02641652 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04355052 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01403051 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01071291 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT04292444 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study NCT01964079 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01964079 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02855476 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT02855476 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02864147 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT01943383 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00091611 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04500717 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03081780 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03081780 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02723344 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02723344 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01101113 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT00258960 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02189837 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01624025 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02671864 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT03507088 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT04168892 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT00886509 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02630394 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT03639779 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT02020278 — Surrogate Endpoint (SUR): Serum sodium
Study NCT00725257 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03232671 — Predictive Biomarker (PRD): MIF mRNA
Genes: MIF; GLIF; MMIF
Study NCT02934399 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT01508884 — Predictive Biomarker (PRD): TLR7 mRNA
Genes: TLR7; UNQ248/PRO285
Study NCT04553393 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04553393 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT04453540 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00635310 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT01849237 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01849237 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT01849237 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01171729 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT00462904 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study NCT00719186 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study NCT00719186 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT00719186 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02566681 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT03399071 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT00699426 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04164849 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04164849 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01908049 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01908049 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT01908049 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT01908049 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01908049 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT00525980 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT02016183 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04404660 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06582537 — Predictive Biomarker (PRD): LAMA2 mRNA
Genes: LAMA2; LAMM
Study NCT01318317 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01318317 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01848925 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04386395 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04386395 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT03766516 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03766516 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT01748201 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT03074344 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03593395 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04622748 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01772290 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT01772290 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT02371434 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00173511 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04766645 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT04766645 — Safety Biomarker (SAF): miR-200c
Genes: MIR200C
Study NCT00026065 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00629018 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02608411 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT00073086 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00652340 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1